Columbia, MONCT04611217Now EnrollingIRB Ready

Dietary Fiber Clinical Trial in Columbia, MO

Access cutting-edge dietary fiber treatment through this clinical trial at a research site in Columbia. Study-provided care at no cost to qualified participants.

Sponsored by University of Missouri-Columbia

Quick Self-Assessment

See if you qualify for this Columbia location

Preparing your pre-screening questions…

Expert Care in Columbia

Access dietary fiber specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related dietary fiber treatment provided free

Apply for This Columbia Location

Check if you qualify for this dietary fiber clinical trial in Columbia, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Columbia

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Columbia site if eligible
  4. 4Begin participation

About This Dietary Fiber Study in Columbia

Strong evidence supports the association between high fiber (HiFi) diets (e.g. legumes, nuts, vegetables) and a reduced risk for chronic conditions such as cardiovascular disease (CVD), type 2 diabetes and some forms of cancer. However, the current U.S. average consumption of dietary fiber of 17g/day is significantly below the recommendation level of 25g/d for women and 38g/d for men. Furthermore, fiber fermentation to produce short chain fatty acid (SCFA) products and alterations in microbial composition and activity may be mechanisms linking a HiFi diet to improved health. Importantly, much of the data, including findings supporting a beneficial role of SCFA have been derived from animal studies. Human studies are now needed to advance the understanding of the translational significance of rodent studies and the potential benefit of fiber on microbial metabolites and cardiometabolic health, glucose regulation, appetite and satiety. The central hypothesis is that that the mechanisms by which dietary fiber provides metabolic benefit include direct physical effects in the upper gastrointestinal tract to slow nutrient absorption, and indirect effects to reduce food intake mediated by SCFA-induced secretion of intestinal hormones resulting in increased satiety. Design: Using fiber derived from peas, Aim 1 will test the effect of a HiFi diet on appetite, satiety, and cardiometabolic health and whether elevated SCFA concentration mediates improved satiety in 44 overweight/obese subjects randomly assigned to receive either a high fiber or a low fiber dietary intervention for four weeks in a parallel arm-repeated measures design. Aim 2 will quantitate the changes in microbial composition and colonic SCFA production rate during HiFi feeding and whether any changes are potential mediators of observed benefits on satiety and cardiometabolic risk factors in 26 subjects assigned to receive a high fiber intervention for 3 weeks in a repeated measures design. Relevance: These studies will significantly expand the understanding of mechanisms by which dietary fiber improves satiety and cardiometabolic health in humans.

Sponsor: University of Missouri-Columbia

Who Can Participate

Inclusion Criteria

Men and women (premenopausal only)
Age 20-55y (Aim 1); 45-55y (Aim 2)
BMI ≥25 or ≤35 kg/m2 (Aim 1); ≥25 or ≤40 (Aim 2)
Weight stable (no fluctuations in body weight of greater than 4 kg in the last 3 months)
Willing to consume a research diet
Willing to provide blood and fecal samples
At least one characteristic of the metabolic syndrome (but not diabetic) 1\. A large waistline: 35 inches or more for women 40 inches or more for men 2. High triglycerides: 150 mg/dL or higher 3. Low HDLc level: \<50 mg/dL for women \<40 mg/dL for men 4. High blood pressure ≥130/85 mmHg 5. Fasting blood sugar ≥100 mg/dL
Pre-diabetes acceptable (glucose \<125 mg/dL or HbA1c \<6.5%)
Stably treated with statin drugs, anti-hypertensives, and anti-depressants. These are acceptable as long as the drug category does not alter appetite, body weight, or the microbiome (if known)

Exclusion Criteria

Pregnant or lactating
Postmenopausal (evidence suggests an interplay between the gut microbiome)
BMI of \<25 or \>35 kg/m2 (Aim 1); \<25 or \>40 kg/m2 (Aim 2)
Use of medications that affect the gut microbiome (e.g. antibiotics)
Taking medications known to affect appetite (e.g., phentermine) or gastrointestinal function (e.g., metformin)
On a special diet or undergoing weight loss, vegetarian, or other restricted dietary patterns
Ad libitum intake of fiber above 25g/day (mean intake in the US population is 17g/day) and \< 10g/d
Ad libitum alcohol intake of greater than 1 drink/d for women and 2 drinks/d for men
History of disease (example colon cancer, HIV, cardiovascular disease, psychiatric disorders, etc.)
Use of tobacco products
Having metal or implants in the body that are not MRI compatible (Aim 1 only)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Columbia?

Yes, this clinical trial (NCT04611217) has an active research site in Columbia, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Dietary Fiber Treatment Options in Columbia, MO

If you're searching for dietary fiber treatment options in Columbia, MO, this clinical trial (NCT04611217) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Columbia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dietary fiber specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all dietary fiber clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Columbia, MO

See all essential tremor clinical trials recruiting in Columbia — not just this study.

Browse Essential Tremor Trials in Columbia

Browse More Trials by Condition

Ready to Join in Columbia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Columbia, MO